Skip to main content

Nasdaq Grants Accelrys Filing Extension for Quarterly Report

NEW YORK, Apr 17 (GenomeWeb News) - The Nasdaq exchange has granted Accelrys an extension to file its quarterly report for the period ended Dec. 31, 2005, the company said today.

 

The filing has been delayed because Accelrys is restating its quarterly financial statements from Jan. 1, 2000, to Sept. 30, 2005.

 

In Febraray, Nasdaq issued Accelrys a noncompliance notice because it had not yet filed its financial statements for its third fiscal quarter.

 

Today, Nasdaq extended the filing date to May 31. Accelrys stated that it expects to complete its quarterly report as well as its restated historical financial statements by that time.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.